Prevention of infection refers to the ability of the vaccine to protect individuals from becoming infected with the tuberculosis (TB) bacteria. A person cannot get TB disease if this person does not get infected. A person who is already infected with the TB bacteria prior to vaccination, may still develop TB disease in this case.
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study
We assessed future costs, cost-savings, and cost-effectiveness of introducing novel TB vaccines in low- and middle-income countries (LMICs) for a range of product characteristics and delivery strategies.